Cancer Screening

Disease screening plans to distinguish malignancy before manifestations show up. This may include blood tests, pee tests, different tests, or restorative imaging. The advantages of screening regarding disease counteractive action, early location and ensuing treatment must be weighed against any harms. Screening can prompt false positive results and consequent intrusive procedures. Screening can likewise prompt false negative results, where a current malignancy is missed. Contention emerges when it is not clear if the advantages of screening exceed the dangers of the screening system itself, and any subsequent indicative tests and medications. Screening tests must be viable, protected, all around endured with acceptably low rates of false positive and false negative results. On the off chance that indications of growth are recognized, more conclusive and obtrusive follow-up tests are performed to achieve a determination. Screening for growth can prompt malignancy aversion and prior determination. Early determination may prompt higher rates of fruitful treatment and developed life. Be that as it may, it might likewise dishonestly seem to build the opportunity to death through lead time inclination or length time predisposition.

  • Screening Mammography
  • Pap Test
  • Overdiagnosis
  • Cancer Risk and Benefits
  • Whole Body Imaging

Related Conference of Cancer Screening

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Cancer Screening Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in